×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Collegium Pharmaceutical Inc. (COLL) NASDAQ

$38.83 (2.09) (-5.10%)

Market Cap: $1.31B

As of 03/28/24 02:45 PM EDT. Market open.

(COLL)

Collegium Pharmaceutical Inc. (COLL)
NASDAQ

$38.83
(2.09) (-5.10%)

Market Cap: $1.31B

As of 03/28/24 02:45 PM EDT. Market open.

Add to Portfolio

collegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the ... read more

collegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the growing problems associated with non-medical use, abuse and misuse of prescription products by leveraging the company’s proprietary deterx® technology platform. deterx technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have a narrow therapeutic index that would benefit from protection against misuse such as breaking, crushing, grinding, or dissolving the product. the deterx technology platform is covered by u.s. and international patents and patent applications. collegium’s lead product candidate, xtampza er™, is an abuse-deterrent, ex read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Ciaffoni
Full Time Employees
252
CEO Compensation (Base)
$317,308
CEO Compensation (Total)
$4.64M
URL
Address
100 Technology Center Dr, Massachusetts, Stoughton, 02072-4710.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Ciaffoni
Full Time Employees
252
CEO Compensation (Base)
$317,308
CEO Compensation (Total)
$4.64M
Address
100 Technology Center Dr, Massachusetts, Stoughton, 02072-4710.
PRICE CHART FOR COLLEGIUM PHARMACEUTICAL INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$40.73
Previous Close
$40.91
Days Range
$40.07 - $40.91
52 week range
$20.83 - $40.91
Volume
305,583
Avg. Volume (30 days)
508,267
Market Cap
$1.31B
Dividend Yield
-
P/E
27.15
Shares Outstanding
31,959,828
Open
$40.73
Previous Close
$40.91
Days Range
$40.07 - $40.91
52 week range
$20.83 - $40.91
Volume
305,583
Avg. Volume (30 days)
508,267
Market Cap
$1.31B
Dividend Yield
-
P/E
27.15
Shares Outstanding
31,959,828
FINANCIAL STATEMENTS FOR COLLEGIUM PHARMACEUTICAL INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR COLLEGIUM PHARMACEUTICAL INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Smith Thomas BEVP and Chief Medical OfficerFeb 29, 2024 Sale$36.7699536,58063,409Mar 04, 2024, 04:26 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 26, 2024 Sale$36.4310,000364,270139,582Feb 28, 2024, 04:14 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 12, 2024 Option Exercise$33.7026,321887,018160,008Feb 14, 2024, 04:15 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 12, 2024 Option Exercise$33.7029,6901,000,553159,063Feb 14, 2024, 04:14 PM
Smith Thomas BEVP and Chief Medical OfficerFeb 12, 2024 Option Exercise$33.703,199107,80665,704Feb 14, 2024, 04:14 PM
Kuhlmann Shirley R.EVP and General CounselFeb 12, 2024 Option Exercise$33.7031,7561,070,177175,019Feb 14, 2024, 04:14 PM
Ciaffoni JosephPresident and CEOFeb 12, 2024 Option Exercise$33.70128,8674,342,818526,289Feb 14, 2024, 04:13 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 16, 2024 Sale$32.2823,560760,519111,322Jan 18, 2024, 04:19 PM
Ciaffoni JosephPresident and CEODec 21, 2023 Option Exercise$21.344,35792,978279,357Dec 22, 2023, 04:36 PM
Ciaffoni JosephPresident and CEODec 21, 2023 Sale$30.384,357132,377275,000Dec 22, 2023, 04:36 PM
Ciaffoni JosephPresident and CEODec 20, 2023 Option Exercise$21.3426,454564,528301,454Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 19, 2023 Option Exercise$21.3414,516309,771289,516Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 18, 2023 Option Exercise$21.3427,798593,209302,798Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 20, 2023 Sale$30.4026,454804,210275,000Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 19, 2023 Sale$30.0314,516435,942275,000Dec 20, 2023, 05:51 PM
Ciaffoni JosephPresident and CEODec 18, 2023 Sale$30.0427,798834,935275,000Dec 20, 2023, 05:51 PM
Kuhlmann Shirley R.EVP and General CounselNov 27, 2023 Option Exercise$15.9025,600407,040145,118Nov 29, 2023, 04:32 PM
Kuhlmann Shirley R.EVP and General CounselNov 27, 2023 Sale$25.7825,600660,014119,518Nov 29, 2023, 04:32 PM
Kuhlmann Shirley R.EVP and General CounselJun 26, 2023 Sale$21.7217,984390,633120,881Jun 28, 2023, 04:08 PM
Ciaffoni JosephPresident and CEOJun 02, 2023 Sale$21.6031,272675,424276,000Jun 02, 2023, 07:08 PM
Ciaffoni JosephPresident and CEOJun 01, 2023 Sale$22.0931,272690,758306,272Jun 02, 2023, 07:08 PM
Ciaffoni JosephPresident and CEOMay 30, 2023 Sale$21.9031,271684,907368,816Jun 01, 2023, 04:15 PM
Ciaffoni JosephPresident and CEOMay 31, 2023 Sale$21.8731,272683,797337,544Jun 01, 2023, 04:15 PM
Tupper ColleenEVP & Chief Financial OfficerMar 15, 2023 Sale$23.7731,640752,165105,420Mar 17, 2023, 04:11 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2023 Option Exercise$26.7524,046643,231167,068Feb 14, 2023, 05:18 PM
Kuhlmann Shirley R.EVP and General CounselFeb 13, 2023 Sale$26.8821,811586,280137,502Feb 14, 2023, 05:18 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2023 Option Exercise$26.7510,854290,345140,947Feb 14, 2023, 05:17 PM
Ciaffoni JosephPresident and CEOFeb 10, 2023 Option Exercise$26.75103,8572,778,175459,823Feb 14, 2023, 05:16 PM
Ciaffoni JosephPresident and CEOFeb 13, 2023 Option Exercise$15.9011,250178,875411,337Feb 14, 2023, 05:16 PM
Ciaffoni JosephPresident and CEOFeb 13, 2023 Sale$26.8811,250302,400400,087Feb 14, 2023, 05:16 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2023 Option Exercise$26.7521,326570,471155,003Feb 14, 2023, 05:15 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 09, 2023 Sale$27.3917,834488,554110,208Jan 11, 2023, 04:06 PM
Heffernan Michael ThomasDirectorDec 27, 2022 Option Exercise$16.1519,815320,01244,018Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 23, 2022 Option Exercise$16.154,98980,57233,012Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 22, 2022 Option Exercise$16.152373,82828,260Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 27, 2022 Sale$23.7319,815470,25328,023Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 23, 2022 Sale$23.004,989114,74728,023Dec 27, 2022, 07:17 PM
Heffernan Michael ThomasDirectorDec 22, 2022 Sale$23.002375,45128,023Dec 27, 2022, 07:17 PM
Ciaffoni JosephPresident and CEODec 27, 2022 Sale$23.752,20452,341249,150Dec 27, 2022, 07:16 PM
Ciaffoni JosephPresident and CEODec 23, 2022 Sale$23.001473,381250,954Dec 27, 2022, 07:16 PM
Ciaffoni JosephPresident and CEODec 22, 2022 Sale$23.001102,530251,101Dec 27, 2022, 07:16 PM
Heffernan Michael ThomasDirectorDec 19, 2022 Option Exercise$16.153,60658,23731,629Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 21, 2022 Option Exercise$16.1546,600752,59074,623Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 20, 2022 Option Exercise$16.1533,758545,19261,781Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 19, 2022 Sale$23.043,60683,08228,023Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 21, 2022 Sale$23.1146,6001,076,92628,023Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 20, 2022 Sale$23.0833,758779,13528,023Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 21, 2022 Sale$23.117,333169,466251,211Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 20, 2022 Sale$23.079,375216,281258,544Dec 21, 2022, 07:28 PM
Ciaffoni JosephPresident and CEODec 19, 2022 Sale$23.011,13426,093267,919Dec 21, 2022, 07:28 PM
Heffernan Michael ThomasDirectorDec 13, 2022 Option Exercise$15.10161,6872,441,404189,710Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 12, 2022 Option Exercise$15.0927,920421,33455,943Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 13, 2022 Sale$22.16161,6873,582,98428,023Dec 14, 2022, 06:06 PM
Heffernan Michael ThomasDirectorDec 12, 2022 Sale$22.0127,920614,51928,023Dec 14, 2022, 06:06 PM
Ciaffoni JosephPresident and CEODec 01, 2022 Option Exercise$15.9076,6531,218,783400,106Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEODec 02, 2022 Sale$23.0754,4001,255,008269,053Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEODec 01, 2022 Sale$22.4776,6531,722,393323,453Dec 05, 2022, 06:16 PM
Ciaffoni JosephPresident and CEONov 28, 2022 Option Exercise$15.9043684323,496Nov 30, 2022, 05:59 PM
Ciaffoni JosephPresident and CEONov 28, 2022 Sale$22.0043946323,453Nov 30, 2022, 05:59 PM
Ciaffoni JosephPresident and CEONov 22, 2022 Option Exercise$15.90651,033323,518Nov 25, 2022, 06:11 PM
Ciaffoni JosephPresident and CEONov 22, 2022 Sale$22.00651,430323,453Nov 25, 2022, 06:11 PM
Ciaffoni JosephPresident and CEONov 18, 2022 Option Exercise$15.901,98931,625325,442Nov 22, 2022, 04:44 PM
Ciaffoni JosephPresident and CEONov 18, 2022 Sale$22.021,98943,798323,453Nov 22, 2022, 04:44 PM
Tupper ColleenEVP & Chief Financial OfficerOct 04, 2022 Sale$17.354,35075,47390,304Oct 06, 2022, 04:23 PM
Kuhlmann Shirley R.EVP and General CounselSep 15, 2022 Sale$18.0738,589697,303109,495Sep 16, 2022, 04:22 PM
Kuhlmann Shirley R.EVP and General CounselAug 11, 2022 Sale$20.013006,003148,084Aug 15, 2022, 04:34 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 11, 2022 Option Exercise$17.4859410,383120,632Jul 13, 2022, 04:50 PM
Ciaffoni JosephPresident and CEOJul 01, 2022 Option Exercise$18.161,39425,315323,453Jul 06, 2022, 04:35 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2022 Option Exercise$18.9973413,939148,384Mar 18, 2022, 04:03 PM
Ciaffoni JosephPresident and CEOMar 01, 2022 Sale$18.4776,0941,405,224335,858Mar 03, 2022, 04:14 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2022 Option Exercise$17.634,05871,54395,891Mar 03, 2022, 04:13 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 18, 2022 Sale$21.6110,559228,180121,226Feb 28, 2022, 04:24 PM
Malamut RichardEVP and Chief Medical OfficerFeb 10, 2022 Option Exercise$17.636,300111,069132,102Feb 14, 2022, 06:49 PM
Tupper ColleenEVP & Chief Financial OfficerFeb 10, 2022 Option Exercise$17.634,05871,54388,891Feb 14, 2022, 06:38 PM
Ciaffoni JosephPresident and CEOFeb 10, 2022 Option Exercise$17.6352,997934,337429,784Feb 14, 2022, 06:37 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2022 Option Exercise$17.6311,179197,086153,330Feb 14, 2022, 06:37 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2022 Option Exercise$17.6310,659187,918135,801Feb 14, 2022, 06:36 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 10, 2022 Option Exercise$19.0570113,35476,269Jan 12, 2022, 04:22 PM
Ciaffoni JosephPresident and CEOJan 03, 2022 Option Exercise$18.681,09020,361263,904Jan 05, 2022, 04:06 PM
Dreyer ScottEVP & Chief Commercial OfficerDec 15, 2021 Sale$18.335,693104,35376,970Dec 17, 2021, 04:33 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2021 Option Exercise$19.6773414,43889,256Sep 20, 2021, 04:03 PM
Fleming Alison BEVP & Chief Technical OfficerAug 10, 2021 Option Exercise$19.031,38626,376143,694Aug 12, 2021, 04:03 PM
Ciaffoni JosephPresident and CEOAug 10, 2021 Option Exercise$19.031,38626,376264,994Aug 12, 2021, 04:01 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 12, 2021 Option Exercise$23.1759513,78682,663Jul 14, 2021, 04:17 PM
Ciaffoni JosephPresident and CEOJul 01, 2021 Option Exercise$23.991,39433,442266,380Jul 06, 2021, 04:03 PM
Kuhlmann Shirley R.EVP and General CounselMay 10, 2021 Sale$22.777,000159,39089,990May 12, 2021, 04:06 PM
Malamut RichardEVP and Chief Medical OfficerApr 01, 2021 Option Exercise$23.383,11972,92293,558Apr 05, 2021, 07:07 PM
Fleming Alison BEVP & Chief Technical OfficerApr 01, 2021 Option Exercise$23.389,657225,781152,980Apr 05, 2021, 06:54 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2021 Option Exercise$24.6973418,12296,990Mar 18, 2021, 04:07 PM
Heffernan Michael ThomasDirectorMar 15, 2021 Sale$25.3050,0751,266,7747,078Mar 17, 2021, 04:03 PM
Ciaffoni JosephPresident and CEOMar 01, 2021 Option Exercise$8.2248,616399,624343,075Mar 03, 2021, 08:02 PM
Ciaffoni JosephPresident and CEOMar 01, 2021 Sale$22.6764,7681,468,425288,116Mar 03, 2021, 08:02 PM
Fleming Alison BChief Technical OfficerJan 19, 2018 Option Exercise$1.953,3246,484157,975Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 12, 2018 Option Exercise$0.587,5004,334161,917Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerMay 10, 2018 Sale$27.001,40037,800154,764Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 19, 2018 Sale$23.003,32476,452156,164Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerJan 12, 2018 Sale$21.007,500157,500156,164Mar 03, 2021, 08:01 PM
Fleming Alison BChief Technical OfficerMar 01, 2021 Sale$23.366,011140,417148,753Mar 03, 2021, 08:01 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2021 Option Exercise$25.955,184134,52594,439Feb 12, 2021, 04:16 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 11, 2021 Sale$25.217,898199,13289,056Feb 12, 2021, 04:16 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2021 Option Exercise$25.955,858152,015101,419Feb 12, 2021, 04:16 PM
Fleming Alison BChief Technical OfficerFeb 10, 2021 Option Exercise$25.957,144185,387161,209Feb 12, 2021, 04:15 PM
Ciaffoni JosephPresident and CEOFeb 10, 2021 Option Exercise$25.9523,786617,247309,747Feb 12, 2021, 04:15 PM
Brannelly PaulExecutive Vice President & CFOFeb 10, 2021 Option Exercise$25.958,491220,341221,355Feb 12, 2021, 04:14 PM
Malamut RichardEVP and Chief Medical OfficerFeb 10, 2021 Option Exercise$25.952,30059,68598,219Feb 12, 2021, 04:13 PM
Kuhlmann Shirley R.EVP and General CounselJan 20, 2021 Sale$24.456,081148,680103,582Jan 22, 2021, 04:05 PM
Kuhlmann Shirley R.EVP and General CounselJan 20, 2021 Sale$24.456,081148,680103,582Jan 21, 2021, 04:29 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 15, 2021 Sale$22.891,32230,26144,395Jan 20, 2021, 04:15 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 11, 2021 Option Exercise$21.1870114,84745,717Jan 13, 2021, 04:08 PM
Fleming Alison BChief Technology OfficerJan 19, 2018 Option Exercise$5.733,33619,115114,755Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 07, 2021 Option Exercise$5.7316,04291,921127,461Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 07, 2021 Sale$22.0016,042352,924111,419Jan 11, 2021, 05:06 PM
Fleming Alison BChief Technology OfficerJan 19, 2018 Sale$23.003,33676,728111,419Jan 11, 2021, 05:06 PM
Ciaffoni JosephPresident and CEOJan 04, 2021 Option Exercise$20.031,09021,833184,256Jan 06, 2021, 04:09 PM
Fleming Alison BChief Technology OfficerDec 03, 2020 Sale$19.245,967114,805111,419Dec 07, 2020, 04:03 PM
Ciaffoni JosephPresident and CEONov 30, 2020 Option Exercise$18.494,67286,385185,346Dec 02, 2020, 05:00 PM
Fleming Alison BChief Technology OfficerNov 18, 2020 Option Exercise$5.7316,00091,680117,386Nov 20, 2020, 04:28 PM
Kuhlmann Shirley R.EVP and General CounselOct 15, 2020 Sale$20.827,060146,98957,531Oct 16, 2020, 04:07 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2020 Option Exercise$19.3373414,18864,591Sep 18, 2020, 04:17 PM
Brannelly PaulExecutive Vice President & CFOAug 10, 2020 Option Exercise$18.891,51528,618173,758Aug 12, 2020, 04:06 PM
Ciaffoni JosephPresident and CEOAug 10, 2020 Option Exercise$18.891,38626,182190,018Aug 12, 2020, 04:05 PM
Heffernan Michael ThomasDirectorAug 11, 2020 Sale$19.1313,071250,04854,122Aug 12, 2020, 04:05 PM
Fleming Alison BChief Technology OfficerAug 10, 2020 Option Exercise$18.891,51528,618101,386Aug 12, 2020, 04:04 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 10, 2020 Option Exercise$16.735949,93847,847Jul 14, 2020, 04:06 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 13, 2020 Sale$17.011,42924,30746,418Jul 14, 2020, 04:06 PM
Ciaffoni JosephPresident and CEOJul 01, 2020 Option Exercise$17.371,39424,214191,404Jul 02, 2020, 04:40 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Option Exercise$21.244,67299,233204,515Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Option Exercise$8.2264,820532,820269,335Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 02, 2020 Sale$20.485,861120,058192,898Jun 02, 2020, 06:58 PM
Ciaffoni JosephPresident and CEOJun 01, 2020 Sale$21.5370,6761,521,709198,759Jun 02, 2020, 06:58 PM
Heffernan Michael ThomasDirectorMay 20, 2020 Option Exercise$22.0518,650411,23263,146May 22, 2020, 04:25 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18, 2020 Option Exercise$15.908,000127,20056,441May 20, 2020, 04:18 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18, 2020 Sale$24.008,000192,00048,441May 20, 2020, 04:18 PM
Heffernan Michael ThomasDirectorMay 13, 2020 Sale$21.6319,254416,42199,670May 15, 2020, 04:17 PM
Fleming Alison BChief Technology OfficerMay 13, 2020 Sale$21.677,989173,147105,629May 15, 2020, 04:16 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 13, 2020 Sale$22.614,434100,25348,441May 15, 2020, 04:15 PM
Malamut RichardEVP and Chief Medical OfficerApr 01, 2020 Option Exercise$15.492,92045,23159,830Apr 03, 2020, 04:16 PM
Kuhlmann Shirley R.EVP and General CounselMar 16, 2020 Option Exercise$15.4173411,31165,325Mar 18, 2020, 04:16 PM
Brannelly PaulExecutive Vice President & CFOFeb 10, 2020 Option Exercise$21.624,02587,021175,273Feb 12, 2020, 04:32 PM
Ciaffoni JosephPresident and CEOFeb 10, 2020 Option Exercise$21.627,499162,128209,187Feb 12, 2020, 04:30 PM
Fleming Alison BChief Technology OfficerFeb 10, 2020 Option Exercise$21.623,56877,140110,890Feb 12, 2020, 04:28 PM
Dreyer ScottEVP & Chief Commercial OfficerFeb 10, 2020 Option Exercise$21.621,96642,50552,875Feb 12, 2020, 04:27 PM
Kuhlmann Shirley R.EVP and General CounselFeb 10, 2020 Option Exercise$21.622,08545,07866,059Feb 12, 2020, 04:25 PM
Heffernan Michael ThomasDirectorFeb 10, 2020 Option Exercise$21.624,962107,278101,050Feb 12, 2020, 04:22 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Option Exercise$21.5678716,968106,012Jan 22, 2020, 04:29 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Option Exercise$5.73275,4631,578,403402,086Jan 22, 2020, 04:29 PM
Heffernan Michael ThomasDirectorJan 21, 2020 Sale$21.93295,2876,476,863139,499Jan 22, 2020, 04:29 PM
Fleming Alison BChief Technology OfficerJan 21, 2020 Option Exercise$21.562144,61473,342Jan 22, 2020, 04:27 PM
Brannelly PaulExecutive Vice President & CFOJan 21, 2020 Option Exercise$21.562144,614151,173Jan 22, 2020, 04:26 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 14, 2020 Sale$23.871,32131,53235,716Jan 16, 2020, 04:12 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 10, 2020 Option Exercise$23.3070216,35737,037Jan 14, 2020, 04:27 PM
Ciaffoni JosephPresident and CEOJan 02, 2020 Option Exercise$20.581,09122,453171,686Jan 03, 2020, 04:07 PM
Ciaffoni JosephPresident and CEONov 29, 2019 Option Exercise$21.734,678101,653172,777Dec 02, 2019, 04:16 PM
Hirsch DavidDirectorNov 08, 2019 Sale$19.3325,000483,25017,117Nov 13, 2019, 04:33 PM
Fleming Alison BChief Technology OfficerNov 08, 2019 Option Exercise$5.7325,000143,25098,556Nov 13, 2019, 04:32 PM
Fleming Alison BChief Technology OfficerNov 08, 2019 Sale$19.4425,000486,00073,556Nov 13, 2019, 04:32 PM
Ciaffoni JosephPresident and CEONov 07, 2019 Option Exercise$8.2264,821532,829242,276Nov 08, 2019, 04:11 PM
Ciaffoni JosephPresident and CEONov 07, 2019 Sale$18.7764,8211,216,774208,681Nov 08, 2019, 04:11 PM
Kuhlmann Shirley R.EVP and General CounselSep 16, 2019 Option Exercise$12.447369,15643,394Sep 18, 2019, 04:06 PM
Hirsch DavidDirectorAug 29, 2019 Option Exercise$9.3319,853185,22864,223Sep 03, 2019, 06:16 PM
Hirsch DavidDirectorAug 29, 2019 Sale$11.6522,106257,53542,117Sep 03, 2019, 06:16 PM
Fleming Alison BChief Technology OfficerAug 09, 2019 Option Exercise$11.241,51717,05173,556Aug 13, 2019, 04:47 PM
Ciaffoni JosephPresident and CEOAug 09, 2019 Option Exercise$11.2491910,330177,455Aug 13, 2019, 04:46 PM
Heffernan Michael ThomasDirectorAug 09, 2019 Option Exercise$11.244,77953,716126,623Aug 13, 2019, 04:45 PM
Brannelly PaulExecutive Vice President & CFOJul 26, 2019 Option Exercise$9.047977,205152,904Aug 13, 2019, 04:42 PM
Brannelly PaulExecutive Vice President & CFOAug 09, 2019 Option Exercise$11.241,51717,051151,387Aug 13, 2019, 04:42 PM
Fleming Alison BChief Technology OfficerJul 19, 2019 Option Exercise$10.351811,87375,073Jul 23, 2019, 04:04 PM
Heffernan Michael ThomasDirectorJul 19, 2019 Option Exercise$10.356676,903131,402Jul 23, 2019, 04:03 PM
Brannelly PaulExecutive Vice President & CFOJul 19, 2019 Option Exercise$10.351811,873152,107Jul 23, 2019, 04:02 PM
Heffernan Michael ThomasDirectorJul 15, 2019 Sale$11.2625,000281,500132,069Jul 17, 2019, 04:22 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 10, 2019 Option Exercise$12.441,19014,80440,596Jul 12, 2019, 04:08 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 11, 2019 Sale$12.312,85735,17037,739Jul 12, 2019, 04:08 PM
Ciaffoni JosephPresident and CEOJul 01, 2019 Option Exercise$13.211,84824,412178,374Jul 02, 2019, 06:15 PM
Heffernan Michael ThomasDirectorJun 17, 2019 Sale$11.3725,000284,246159,090Jun 19, 2019, 06:05 PM
Ciaffoni JosephPresident and CEOMay 31, 2019 Option Exercise$11.513,09735,646187,658Jun 04, 2019, 04:17 PM
Ciaffoni JosephPresident and CEOJun 03, 2019 Sale$11.597,43686,183180,222Jun 04, 2019, 04:17 PM
Ciaffoni JosephPresident and CEOMay 31, 2019 Sale$11.525,85167,404190,755Jun 04, 2019, 04:17 PM
Heffernan Michael ThomasDirectorMay 15, 2019 Sale$12.8425,000321,042188,586May 17, 2019, 04:04 PM
Heffernan Michael ThomasDirectorApr 15, 2019 Sale$15.0925,000377,366207,170Apr 17, 2019, 04:24 PM
Kuhlmann Shirley R.EVP and General CounselMar 15, 2019 Option Exercise$16.981,47024,96144,130Mar 19, 2019, 05:41 PM
Heffernan Michael ThomasDirectorMar 15, 2019 Sale$17.1725,000429,250227,362Mar 19, 2019, 05:36 PM
Heffernan Michael ThomasDirectorFeb 15, 2019 Sale$14.8125,000370,224259,430Feb 20, 2019, 12:00 AM
Heffernan Michael ThomasDirectorFeb 08, 2019 Option Exercise$14.397,851112,976277,362Feb 11, 2019, 05:06 PM
Fleming Alison BChief Technology OfficerFeb 08, 2019 Option Exercise$14.392,71439,05475,254Feb 11, 2019, 05:03 PM
Ciaffoni JosephPresident and CEOFeb 08, 2019 Option Exercise$14.392,05229,528196,606Feb 11, 2019, 05:01 PM
Brannelly PaulExecutive Vice President & CFOFeb 08, 2019 Option Exercise$14.392,69338,752152,288Feb 11, 2019, 04:59 PM
Fleming Alison BChief Technology OfficerJan 18, 2019 Option Exercise$15.762143,37352,368Jan 23, 2019, 04:17 PM
Heffernan Michael ThomasDirectorJan 18, 2019 Option Exercise$15.7678712,403285,213Jan 23, 2019, 04:14 PM
Brannelly PaulExecutive Vice President & CFOJan 18, 2019 Option Exercise$15.762143,373122,981Jan 23, 2019, 04:13 PM
Heffernan Michael ThomasDirectorJan 15, 2019 Sale$15.5625,000389,000286,000Jan 17, 2019, 04:16 PM
Heffernan Michael ThomasDirectorDec 17, 2018 Sale$18.1825,000454,491314,313Dec 18, 2018, 05:09 PM
Ciaffoni JosephPresident and CEONov 30, 2018 Option Exercise$19.194,68389,867108,658Dec 03, 2018, 05:05 PM
Heffernan Michael ThomasDirectorNov 15, 2018 Sale$16.6025,000415,122339,600Nov 16, 2018, 04:19 PM
Heffernan Michael ThomasDirectorOct 15, 2018 Sale$16.5325,000413,250361,000Oct 17, 2018, 04:27 PM
Brannelly PaulExecutive Vice President & CFOAug 23, 2018 Option Exercise$18.0359910,800123,195Aug 27, 2018, 04:07 PM
Heffernan Michael ThomasDirectorAug 23, 2018 Option Exercise$18.032,02536,511386,000Aug 27, 2018, 04:06 PM
Fleming Alison BChief Technology OfficerAug 23, 2018 Option Exercise$18.0359910,80052,582Aug 27, 2018, 04:04 PM
Brannelly PaulExecutive Vice President & CFOJul 27, 2018 Option Exercise$15.845398,538123,975Aug 06, 2018, 05:43 PM
Brannelly PaulExecutive Vice President & CFOAug 03, 2018 Option Exercise$20.151813,647123,794Aug 06, 2018, 05:43 PM
Heffernan Michael ThomasDirectorAug 03, 2018 Option Exercise$20.1566813,460388,025Aug 06, 2018, 05:41 PM
Fleming Alison BChief Technology OfficerAug 03, 2018 Option Exercise$20.151813,64753,181Aug 06, 2018, 05:39 PM
Brannelly PaulExecutive Vice President & CFOJun 21, 2018 Sale$27.9210,000279,165128,336Jun 22, 2018, 06:25 PM
Fleming Alison BChief Technology OfficerJun 12, 2018 Sale$27.004,096110,59253,362Jun 13, 2018, 04:58 PM
Heffernan Michael ThomasChairman, President and CEOJun 11, 2018 Sale$25.2896,9432,450,719441,750Jun 13, 2018, 04:56 PM
Heffernan Michael ThomasChairman, President and CEOJun 12, 2018 Sale$25.2653,0571,340,220388,693Jun 13, 2018, 04:56 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Option Exercise$22.626,205140,357103,063Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Option Exercise$8.2264,821532,829174,089Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerJun 01, 2018 Sale$22.4814,862334,09888,201Jun 04, 2018, 06:00 PM
Ciaffoni JosephChief Operating OfficerMay 31, 2018 Sale$22.6164,8211,465,615114,885Jun 04, 2018, 06:00 PM
Heffernan Michael ThomasChairman, President and CEOMay 10, 2018 Sale$26.217,100186,100540,193May 14, 2018, 04:32 PM
Heffernan Michael ThomasChairman, President and CEOApr 19, 2018 Sale$26.0044,4001,154,401545,893Apr 23, 2018, 05:05 PM
Fleming Alison BChief Technology OfficerApr 02, 2018 Option Exercise$0.288,1422,28057,458Apr 04, 2018, 04:50 PM
Heffernan Michael ThomasChairman, President and CEOFeb 26, 2018 Option Exercise$21.774,05088,169590,193Mar 01, 2018, 04:04 PM
Brannelly PaulExecutive Vice President & CFOFeb 26, 2018 Option Exercise$21.771,19726,059133,436Mar 01, 2018, 04:03 PM
Fleming Alison BChief Technology OfficerFeb 26, 2018 Option Exercise$21.771,19325,97249,316Mar 01, 2018, 04:03 PM
Brannelly PaulExecutive Vice President & CFOFeb 05, 2018 Option Exercise$23.382145,003134,633Feb 06, 2018, 04:18 PM
Fleming Alison BChief Technology OfficerFeb 05, 2018 Option Exercise$23.382145,00350,509Feb 06, 2018, 04:16 PM
Heffernan Michael ThomasChairman, President and CEOFeb 05, 2018 Option Exercise$23.3878818,423594,243Feb 06, 2018, 04:14 PM
Heffernan Michael ThomasChairman, President and CEOJan 26, 2018 Option Exercise$10.171,04410,617595,031Jan 29, 2018, 07:41 PM
Brannelly PaulExecutive Vice President & CFOJan 26, 2018 Option Exercise$10.171,04410,617134,847Jan 29, 2018, 07:38 PM
Heffernan Michael ThomasChairman, President and CEOJan 23, 2018 Sale$25.0116,408410,364518,987Jan 23, 2018, 05:41 PM
Heffernan Michael ThomasChairman, President and CEOJan 22, 2018 Sale$25.003,59289,800535,395Jan 23, 2018, 05:41 PM
Heffernan Michael ThomasChairman, President and CEOJan 19, 2018 Sale$22.5020,000450,000538,987Jan 19, 2018, 05:41 PM
Fleming Alison BChief Technology OfficerJan 10, 2018 Option Exercise$0.486,9283,32532,651Jan 12, 2018, 04:15 PM
Fleming Alison BChief Technology OfficerJan 10, 2018 Sale$19.076,928132,11725,723Jan 12, 2018, 04:15 PM
Hirsch DavidDirectorDec 08, 2017 Sale$17.3419,650340,73145,620Dec 12, 2017, 04:23 PM
Hirsch DavidDirectorDec 08, 2017 Sale$17.34980,35016,999,2692,276,222Dec 12, 2017, 04:23 PM
Longitude Capital Partners, LLC10% OwnerDec 08, 2017 Sale$17.3419,650340,73145,620Dec 12, 2017, 04:20 PM
Longitude Capital Partners, LLC10% OwnerDec 08, 2017 Sale$17.34980,35016,999,2692,276,222Dec 12, 2017, 04:20 PM
Fleming Alison BChief Technology OfficerNov 21, 2017 Option Exercise$0.2857216026,295Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 17, 2017 Option Exercise$0.283,18989328,513Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 21, 2017 Sale$19.0057210,86825,723Nov 21, 2017, 05:41 PM
Fleming Alison BChief Technology OfficerNov 17, 2017 Sale$17.004,02968,49326,563Nov 21, 2017, 05:41 PM
Heffernan Michael ThomasChairman, President and CEONov 15, 2017 Sale$15.5350,000776,500558,987Nov 17, 2017, 09:04 PM
Fleming Alison BChief Technology OfficerOct 25, 2017 Option Exercise$3.381,8116,12126,563Oct 27, 2017, 04:58 PM
Heffernan Michael ThomasChairman, President and CEOJul 28, 2017 Option Exercise$10.606406,784609,723Aug 04, 2017, 04:17 PM
Heffernan Michael ThomasChairman, President and CEOAug 04, 2017 Option Exercise$12.397369,119608,987Aug 04, 2017, 04:17 PM
Brannelly PaulExecutive Vice President & CFOJul 28, 2017 Option Exercise$10.607768,226111,003Aug 04, 2017, 04:15 PM
Brannelly PaulExecutive Vice President & CFOAug 04, 2017 Option Exercise$12.392002,478110,803Aug 04, 2017, 04:15 PM
Fleming Alison BChief Technology OfficerJul 28, 2017 Option Exercise$10.606396,77324,952Aug 04, 2017, 04:14 PM
Fleming Alison BChief Technology OfficerAug 04, 2017 Option Exercise$12.392002,47824,752Aug 04, 2017, 04:14 PM
Brannelly PaulExecutive Vice President & CFOMay 12, 2017 Buy$9.1810,00091,800110,227May 15, 2017, 05:26 PM
Heffernan Michael ThomasChairman, President and CEOMar 17, 2017 Option Exercise$14.951,47222,006609,083Mar 21, 2017, 04:45 PM
Brannelly PaulExecutive Vice President & CFOMar 17, 2017 Option Exercise$14.953885,801100,227Mar 21, 2017, 04:44 PM
Duke Barry SSee remarksMar 17, 2017 Option Exercise$14.953885,80120,087Mar 21, 2017, 04:43 PM
Fleming Alison BChief Technology OfficerMar 17, 2017 Option Exercise$14.953885,80124,313Mar 21, 2017, 04:42 PM
Fleming Alison BChief Technology OfficerJan 27, 2017 Option Exercise$10.081,24012,4998,451Feb 14, 2017, 05:56 PM
Duke Barry SSee remarksJan 27, 2017 Option Exercise$10.088348,4076,725Feb 14, 2017, 05:54 PM
Brannelly PaulExecutive Vice President & CFOJan 27, 2017 Option Exercise$10.081,00610,14084,365Feb 14, 2017, 05:53 PM
Heffernan Michael ThomasChairman, President and CEOJan 27, 2017 Option Exercise$10.081,23912,489552,542Feb 02, 2017, 04:26 PM
Heffernan Michael ThomasChairman, President and CEOJan 31, 2017 Option Exercise$0.483,0131,446555,555Feb 02, 2017, 04:26 PM
Fallon John A.DirectorAug 12, 2016 Buy$10.592,37525,1512,375Aug 15, 2016, 08:54 PM
Heffernan Michael ThomasChairman, President and CEOJul 29, 2016 Option Exercise$10.311,21212,496551,303Aug 03, 2016, 04:22 PM
Brannelly PaulExecutive Vice President & CFOJul 29, 2016 Option Exercise$10.3198310,13583,359Aug 03, 2016, 04:20 PM
Duke Barry SSee remarksJul 29, 2016 Option Exercise$10.3197810,0835,891Aug 03, 2016, 04:18 PM
Brannelly PaulExecutive Vice President & CFOMay 20, 2016 Option Exercise$16.891,10018,57982,376May 23, 2016, 12:40 PM
Brannelly PaulExecutive Vice President & CFOMay 18, 2016 Option Exercise$16.0090014,40081,276May 19, 2016, 04:50 PM
Brannelly PaulExecutive Vice President & CFOMay 17, 2016 Option Exercise$15.461,00015,46080,376May 18, 2016, 01:14 PM
Brannelly PaulExecutive Vice President & CFOMay 16, 2016 Option Exercise$15.7380012,58479,376May 16, 2016, 04:40 PM
Brannelly PaulExecutive Vice President & CFOMay 13, 2016 Option Exercise$15.021,20018,02478,576May 13, 2016, 04:26 PM
Heffernan Michael ThomasChairman, President and CEOApr 05, 2016 Option Exercise$2.4913,60433,905387,048Apr 07, 2016, 05:03 PM
Longitude Capital Partners, LLC10% OwnerMay 12, 2015 Buy$12.003,93047,16065,270May 14, 2015, 04:25 PM
Longitude Capital Partners, LLC10% OwnerMay 12, 2015 Buy$12.00196,0702,352,8403,256,572May 14, 2015, 04:25 PM
Heron Patrick JDirectorMay 12, 2015 Buy$12.00150,0001,800,0001,887,332May 14, 2015, 04:06 PM
Frazier Healthcare VI, L.P.10% OwnerMay 12, 2015 Buy$12.00150,0001,800,0001,887,332May 14, 2015, 04:06 PM
TPG Group Holdings (SBS) Advisors, Inc.Former 10% OwnerMay 12, 2015 Buy$12.00100,0001,200,0001,325,253May 14, 2015, 02:55 PM
Skyline Venture Partners V LP10% OwnerMay 12, 2015 Buy$12.00150,0001,800,0002,949,916May 13, 2015, 09:41 PM
Hirsch DavidDirectorMay 12, 2015 Buy$12.00196,0702,352,8403,256,572May 13, 2015, 04:37 PM
Hirsch DavidDirectorMay 12, 2015 Buy$12.003,93047,16065,270May 13, 2015, 04:37 PM
Freund John GordonDirectorMay 12, 2015 Buy$12.00150,0001,800,0002,949,916May 13, 2015, 04:31 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Smith Thomas BEVP and Chief Medical Officer02/29/202436,580
Dreyer ScottEVP & Chief Commercial Officer02/26/2024364,270
Tupper ColleenEVP & Chief Financial Officer02/12/2024887,018
Dreyer ScottEVP & Chief Commercial Officer02/12/20241,000,553
Smith Thomas BEVP and Chief Medical Officer02/12/2024107,806
Kuhlmann Shirley R.EVP and General Counsel02/12/20241,070,177
Ciaffoni JosephPresident and CEO02/12/20244,342,818
Dreyer ScottEVP & Chief Commercial Officer01/16/2024760,519
Ciaffoni JosephPresident and CEO12/21/202392,978
Ciaffoni JosephPresident and CEO12/21/2023132,377
Ciaffoni JosephPresident and CEO12/20/2023564,528
Ciaffoni JosephPresident and CEO12/19/2023309,771
Ciaffoni JosephPresident and CEO12/18/2023593,209
Ciaffoni JosephPresident and CEO12/20/2023804,210
Ciaffoni JosephPresident and CEO12/19/2023435,942
Ciaffoni JosephPresident and CEO12/18/2023834,935
Kuhlmann Shirley R.EVP and General Counsel11/27/2023407,040
Kuhlmann Shirley R.EVP and General Counsel11/27/2023660,014
Kuhlmann Shirley R.EVP and General Counsel06/26/2023390,633
Ciaffoni JosephPresident and CEO06/02/2023675,424
Ciaffoni JosephPresident and CEO06/01/2023690,758
Ciaffoni JosephPresident and CEO05/30/2023684,907
Ciaffoni JosephPresident and CEO05/31/2023683,797
Tupper ColleenEVP & Chief Financial Officer03/15/2023752,165
Kuhlmann Shirley R.EVP and General Counsel02/10/2023643,231
Kuhlmann Shirley R.EVP and General Counsel02/13/2023586,280
Tupper ColleenEVP & Chief Financial Officer02/10/2023290,345
Ciaffoni JosephPresident and CEO02/10/20232,778,175
Ciaffoni JosephPresident and CEO02/13/2023178,875
Ciaffoni JosephPresident and CEO02/13/2023302,400
Dreyer ScottEVP & Chief Commercial Officer02/10/2023570,471
Dreyer ScottEVP & Chief Commercial Officer01/09/2023488,554
Heffernan Michael ThomasDirector12/27/2022320,012
Heffernan Michael ThomasDirector12/23/202280,572
Heffernan Michael ThomasDirector12/22/20223,828
Heffernan Michael ThomasDirector12/27/2022470,253
Heffernan Michael ThomasDirector12/23/2022114,747
Heffernan Michael ThomasDirector12/22/20225,451
Ciaffoni JosephPresident and CEO12/27/202252,341
Ciaffoni JosephPresident and CEO12/23/20223,381
Ciaffoni JosephPresident and CEO12/22/20222,530
Heffernan Michael ThomasDirector12/19/202258,237
Heffernan Michael ThomasDirector12/21/2022752,590
Heffernan Michael ThomasDirector12/20/2022545,192
Heffernan Michael ThomasDirector12/19/202283,082
Heffernan Michael ThomasDirector12/21/20221,076,926
Heffernan Michael ThomasDirector12/20/2022779,135
Ciaffoni JosephPresident and CEO12/21/2022169,466
Ciaffoni JosephPresident and CEO12/20/2022216,281
Ciaffoni JosephPresident and CEO12/19/202226,093
Heffernan Michael ThomasDirector12/13/20222,441,404
Heffernan Michael ThomasDirector12/12/2022421,334
Heffernan Michael ThomasDirector12/13/20223,582,984
Heffernan Michael ThomasDirector12/12/2022614,519
Ciaffoni JosephPresident and CEO12/01/20221,218,783
Ciaffoni JosephPresident and CEO12/02/20221,255,008
Ciaffoni JosephPresident and CEO12/01/20221,722,393
Ciaffoni JosephPresident and CEO11/28/2022684
Ciaffoni JosephPresident and CEO11/28/2022946
Ciaffoni JosephPresident and CEO11/22/20221,033
Ciaffoni JosephPresident and CEO11/22/20221,430
Ciaffoni JosephPresident and CEO11/18/202231,625
Ciaffoni JosephPresident and CEO11/18/202243,798
Tupper ColleenEVP & Chief Financial Officer10/04/202275,473
Kuhlmann Shirley R.EVP and General Counsel09/15/2022697,303
Kuhlmann Shirley R.EVP and General Counsel08/11/20226,003
Dreyer ScottEVP & Chief Commercial Officer07/11/202210,383
Ciaffoni JosephPresident and CEO07/01/202225,315
Kuhlmann Shirley R.EVP and General Counsel03/16/202213,939
Ciaffoni JosephPresident and CEO03/01/20221,405,224
Tupper ColleenEVP & Chief Financial Officer02/10/202271,543
Dreyer ScottEVP & Chief Commercial Officer02/18/2022228,180
Malamut RichardEVP and Chief Medical Officer02/10/2022111,069
Tupper ColleenEVP & Chief Financial Officer02/10/202271,543
Ciaffoni JosephPresident and CEO02/10/2022934,337
Kuhlmann Shirley R.EVP and General Counsel02/10/2022197,086
Dreyer ScottEVP & Chief Commercial Officer02/10/2022187,918
Dreyer ScottEVP & Chief Commercial Officer01/10/202213,354
Ciaffoni JosephPresident and CEO01/03/202220,361
Dreyer ScottEVP & Chief Commercial Officer12/15/2021104,353
Kuhlmann Shirley R.EVP and General Counsel09/16/202114,438
Fleming Alison BEVP & Chief Technical Officer08/10/202126,376
Ciaffoni JosephPresident and CEO08/10/202126,376
Dreyer ScottEVP & Chief Commercial Officer07/12/202113,786
Ciaffoni JosephPresident and CEO07/01/202133,442
Kuhlmann Shirley R.EVP and General Counsel05/10/2021159,390
Malamut RichardEVP and Chief Medical Officer04/01/202172,922
Fleming Alison BEVP & Chief Technical Officer04/01/2021225,781
Kuhlmann Shirley R.EVP and General Counsel03/16/202118,122
Heffernan Michael ThomasDirector03/15/20211,266,774
Ciaffoni JosephPresident and CEO03/01/2021399,624
Ciaffoni JosephPresident and CEO03/01/20211,468,425
Fleming Alison BChief Technical Officer01/19/20186,484
Fleming Alison BChief Technical Officer01/12/20184,334
Fleming Alison BChief Technical Officer05/10/201837,800
Fleming Alison BChief Technical Officer01/19/201876,452
Fleming Alison BChief Technical Officer01/12/2018157,500
Fleming Alison BChief Technical Officer03/01/2021140,417
Dreyer ScottEVP & Chief Commercial Officer02/10/2021134,525
Dreyer ScottEVP & Chief Commercial Officer02/11/2021199,132
Kuhlmann Shirley R.EVP and General Counsel02/10/2021152,015
Fleming Alison BChief Technical Officer02/10/2021185,387
Ciaffoni JosephPresident and CEO02/10/2021617,247
Brannelly PaulExecutive Vice President & CFO02/10/2021220,341
Malamut RichardEVP and Chief Medical Officer02/10/202159,685
Kuhlmann Shirley R.EVP and General Counsel01/20/2021148,680
Kuhlmann Shirley R.EVP and General Counsel01/20/2021148,680
Dreyer ScottEVP & Chief Commercial Officer01/15/202130,261
Dreyer ScottEVP & Chief Commercial Officer01/11/202114,847
Fleming Alison BChief Technology Officer01/19/201819,115
Fleming Alison BChief Technology Officer01/07/202191,921
Fleming Alison BChief Technology Officer01/07/2021352,924
Fleming Alison BChief Technology Officer01/19/201876,728
Ciaffoni JosephPresident and CEO01/04/202121,833
Fleming Alison BChief Technology Officer12/03/2020114,805
Ciaffoni JosephPresident and CEO11/30/202086,385
Fleming Alison BChief Technology Officer11/18/202091,680
Kuhlmann Shirley R.EVP and General Counsel10/15/2020146,989
Kuhlmann Shirley R.EVP and General Counsel09/16/202014,188
Brannelly PaulExecutive Vice President & CFO08/10/202028,618
Ciaffoni JosephPresident and CEO08/10/202026,182
Heffernan Michael ThomasDirector08/11/2020250,048
Fleming Alison BChief Technology Officer08/10/202028,618
Dreyer ScottEVP & Chief Commercial Officer07/10/20209,938
Dreyer ScottEVP & Chief Commercial Officer07/13/202024,307
Ciaffoni JosephPresident and CEO07/01/202024,214
Ciaffoni JosephPresident and CEO06/01/202099,233
Ciaffoni JosephPresident and CEO06/01/2020532,820
Ciaffoni JosephPresident and CEO06/02/2020120,058
Ciaffoni JosephPresident and CEO06/01/20201,521,709
Heffernan Michael ThomasDirector05/20/2020411,232
Dreyer ScottEVP & Chief Commercial Officer05/18/2020127,200
Dreyer ScottEVP & Chief Commercial Officer05/18/2020192,000
Heffernan Michael ThomasDirector05/13/2020416,421
Fleming Alison BChief Technology Officer05/13/2020173,147
Dreyer ScottEVP & Chief Commercial Officer05/13/2020100,253
Malamut RichardEVP and Chief Medical Officer04/01/202045,231
Kuhlmann Shirley R.EVP and General Counsel03/16/202011,311
Brannelly PaulExecutive Vice President & CFO02/10/202087,021
Ciaffoni JosephPresident and CEO02/10/2020162,128
Fleming Alison BChief Technology Officer02/10/202077,140
Dreyer ScottEVP & Chief Commercial Officer02/10/202042,505
Kuhlmann Shirley R.EVP and General Counsel02/10/202045,078
Heffernan Michael ThomasDirector02/10/2020107,278
Heffernan Michael ThomasDirector01/21/202016,968
Heffernan Michael ThomasDirector01/21/20201,578,403
Heffernan Michael ThomasDirector01/21/20206,476,863
Fleming Alison BChief Technology Officer01/21/20204,614
Brannelly PaulExecutive Vice President & CFO01/21/20204,614
Dreyer ScottEVP & Chief Commercial Officer01/14/202031,532
Dreyer ScottEVP & Chief Commercial Officer01/10/202016,357
Ciaffoni JosephPresident and CEO01/02/202022,453
Ciaffoni JosephPresident and CEO11/29/2019101,653
Hirsch DavidDirector11/08/2019483,250
Fleming Alison BChief Technology Officer11/08/2019143,250
Fleming Alison BChief Technology Officer11/08/2019486,000
Ciaffoni JosephPresident and CEO11/07/2019532,829
Ciaffoni JosephPresident and CEO11/07/20191,216,774
Kuhlmann Shirley R.EVP and General Counsel09/16/20199,156
Hirsch DavidDirector08/29/2019185,228
Hirsch DavidDirector08/29/2019257,535
Fleming Alison BChief Technology Officer08/09/201917,051
Ciaffoni JosephPresident and CEO08/09/201910,330
Heffernan Michael ThomasDirector08/09/201953,716
Brannelly PaulExecutive Vice President & CFO07/26/20197,205
Brannelly PaulExecutive Vice President & CFO08/09/201917,051
Fleming Alison BChief Technology Officer07/19/20191,873
Heffernan Michael ThomasDirector07/19/20196,903
Brannelly PaulExecutive Vice President & CFO07/19/20191,873
Heffernan Michael ThomasDirector07/15/2019281,500
Dreyer ScottEVP & Chief Commercial Officer07/10/201914,804
Dreyer ScottEVP & Chief Commercial Officer07/11/201935,170
Ciaffoni JosephPresident and CEO07/01/201924,412
Heffernan Michael ThomasDirector06/17/2019284,246
Ciaffoni JosephPresident and CEO05/31/201935,646
Ciaffoni JosephPresident and CEO06/03/201986,183
Ciaffoni JosephPresident and CEO05/31/201967,404
Heffernan Michael ThomasDirector05/15/2019321,042
Heffernan Michael ThomasDirector04/15/2019377,366
Kuhlmann Shirley R.EVP and General Counsel03/15/201924,961
Heffernan Michael ThomasDirector03/15/2019429,250
Heffernan Michael ThomasDirector02/15/2019370,224
Heffernan Michael ThomasDirector02/08/2019112,976
Fleming Alison BChief Technology Officer02/08/201939,054
Ciaffoni JosephPresident and CEO02/08/201929,528
Brannelly PaulExecutive Vice President & CFO02/08/201938,752
Fleming Alison BChief Technology Officer01/18/20193,373
Heffernan Michael ThomasDirector01/18/201912,403
Brannelly PaulExecutive Vice President & CFO01/18/20193,373
Heffernan Michael ThomasDirector01/15/2019389,000
Heffernan Michael ThomasDirector12/17/2018454,491
Ciaffoni JosephPresident and CEO11/30/201889,867
Heffernan Michael ThomasDirector11/15/2018415,122
Heffernan Michael ThomasDirector10/15/2018413,250
Brannelly PaulExecutive Vice President & CFO08/23/201810,800
Heffernan Michael ThomasDirector08/23/201836,511
Fleming Alison BChief Technology Officer08/23/201810,800
Brannelly PaulExecutive Vice President & CFO07/27/20188,538
Brannelly PaulExecutive Vice President & CFO08/03/20183,647
Heffernan Michael ThomasDirector08/03/201813,460
Fleming Alison BChief Technology Officer08/03/20183,647
Brannelly PaulExecutive Vice President & CFO06/21/2018279,165
Fleming Alison BChief Technology Officer06/12/2018110,592
Heffernan Michael ThomasChairman, President and CEO06/11/20182,450,719
Heffernan Michael ThomasChairman, President and CEO06/12/20181,340,220
Ciaffoni JosephChief Operating Officer05/31/2018140,357
Ciaffoni JosephChief Operating Officer05/31/2018532,829
Ciaffoni JosephChief Operating Officer06/01/2018334,098
Ciaffoni JosephChief Operating Officer05/31/20181,465,615
Heffernan Michael ThomasChairman, President and CEO05/10/2018186,100
Heffernan Michael ThomasChairman, President and CEO04/19/20181,154,401
Fleming Alison BChief Technology Officer04/02/20182,280
Heffernan Michael ThomasChairman, President and CEO02/26/201888,169
Brannelly PaulExecutive Vice President & CFO02/26/201826,059
Fleming Alison BChief Technology Officer02/26/201825,972
Brannelly PaulExecutive Vice President & CFO02/05/20185,003
Fleming Alison BChief Technology Officer02/05/20185,003
Heffernan Michael ThomasChairman, President and CEO02/05/201818,423
Heffernan Michael ThomasChairman, President and CEO01/26/201810,617
Brannelly PaulExecutive Vice President & CFO01/26/201810,617
Heffernan Michael ThomasChairman, President and CEO01/23/2018410,364
Heffernan Michael ThomasChairman, President and CEO01/22/201889,800
Heffernan Michael ThomasChairman, President and CEO01/19/2018450,000
Fleming Alison BChief Technology Officer01/10/20183,325
Fleming Alison BChief Technology Officer01/10/2018132,117
Hirsch DavidDirector12/08/2017340,731
Hirsch DavidDirector12/08/201716,999,269
Longitude Capital Partners, LLC10% Owner12/08/2017340,731
Longitude Capital Partners, LLC10% Owner12/08/201716,999,269
Fleming Alison BChief Technology Officer11/21/2017160
Fleming Alison BChief Technology Officer11/17/2017893
Fleming Alison BChief Technology Officer11/21/201710,868
Fleming Alison BChief Technology Officer11/17/201768,493
Heffernan Michael ThomasChairman, President and CEO11/15/2017776,500
Fleming Alison BChief Technology Officer10/25/20176,121
Heffernan Michael ThomasChairman, President and CEO07/28/20176,784
Heffernan Michael ThomasChairman, President and CEO08/04/20179,119
Brannelly PaulExecutive Vice President & CFO07/28/20178,226
Brannelly PaulExecutive Vice President & CFO08/04/20172,478
Fleming Alison BChief Technology Officer07/28/20176,773
Fleming Alison BChief Technology Officer08/04/20172,478
Brannelly PaulExecutive Vice President & CFO05/12/201791,800
Heffernan Michael ThomasChairman, President and CEO03/17/201722,006
Brannelly PaulExecutive Vice President & CFO03/17/20175,801
Duke Barry SSee remarks03/17/20175,801
Fleming Alison BChief Technology Officer03/17/20175,801
Fleming Alison BChief Technology Officer01/27/201712,499
Duke Barry SSee remarks01/27/20178,407
Brannelly PaulExecutive Vice President & CFO01/27/201710,140
Heffernan Michael ThomasChairman, President and CEO01/27/201712,489
Heffernan Michael ThomasChairman, President and CEO01/31/20171,446
Fallon John A.Director08/12/201625,151
Heffernan Michael ThomasChairman, President and CEO07/29/201612,496
Brannelly PaulExecutive Vice President & CFO07/29/201610,135
Duke Barry SSee remarks07/29/201610,083
Brannelly PaulExecutive Vice President & CFO05/20/201618,579
Brannelly PaulExecutive Vice President & CFO05/18/201614,400
Brannelly PaulExecutive Vice President & CFO05/17/201615,460
Brannelly PaulExecutive Vice President & CFO05/16/201612,584
Brannelly PaulExecutive Vice President & CFO05/13/201618,024
Heffernan Michael ThomasChairman, President and CEO04/05/201633,905
Longitude Capital Partners, LLC10% Owner05/12/201547,160
Longitude Capital Partners, LLC10% Owner05/12/20152,352,840
Heron Patrick JDirector05/12/20151,800,000
Frazier Healthcare VI, L.P.10% Owner05/12/20151,800,000
TPG Group Holdings (SBS) Advisors, Inc.Former 10% Owner05/12/20151,200,000
Skyline Venture Partners V LP10% Owner05/12/20151,800,000
Hirsch DavidDirector05/12/20152,352,840
Hirsch DavidDirector05/12/201547,160
Freund John GordonDirector05/12/20151,800,000
Load More Insider Transactions
FUNDS WITH A POSITION IN COLLEGIUM PHARMACEUTICAL INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,786,9930.00454%-7.27%Other
RENAISSANCE TECHNOLOGIES LLC1,384,5980.07%18.08%Other
GEODE CAPITAL MANAGEMENT, LLC731,2660.00236%2.87%Other
D. E. SHAW & CO., INC.221,5050.00596%52.6%Other
ROYCE & ASSOCIATES LP143,0830.04%573.97%Value
AQR CAPITAL MANAGEMENT LLC105,1660.00609%0.7%Other
THIRD AVENUE MANAGEMENT LLC83,1200.42%NewValue
FISHER ASSET MANAGEMENT, LLC58,7420.00086%ExitedOther
EASTERLY INVESTMENT PARTNERS LLC49,6510.16%No changeOther
GOTHAM ASSET MANAGEMENT, LLC44,8620.03%4.42%Other
BALYASNY ASSET MANAGEMENT L.P.14,8180.00086%NewEvent Driven
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)8,6670.00493%NewOther
CHANGE IN SHARES OUTSTANDING FOR COLLEGIUM PHARMACEUTICAL INC
STOCK BUYBACKS FOR COLLEGIUM PHARMACEUTICAL INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-0.64%
1Q
12/31/2023
06/30/2023
-2.48%
2Q
12/31/2023
03/31/2023
21.76%
3Q
12/31/2023
12/31/2022
24.45%
4Q
12/31/2023
09/30/2022
20.88%
5Q
12/31/2023
06/30/2022
22.90%
6Q
12/31/2023
03/31/2022
24.10%
7Q
12/31/2023
12/31/2021
3.54%
8Q
12/31/2023
09/30/2021
15.24%
9Q
12/31/2023
06/30/2021
1.21%
10Q
12/31/2023
03/31/2021
1.53%
11Q
12/31/2023
12/31/2020
17.91%
12Q
12/31/2023
09/30/2020
19.16%
13Q
12/31/2023
06/30/2020
19.08%
14Q
12/31/2023
03/31/2020
19.16%
15Q
12/31/2023
12/31/2019
23.87%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-0.64%
1Q
06/30/2023
-2.48%
2Q
03/31/2023
21.76%
3Q
12/31/2022
24.45%
4Q
09/30/2022
20.88%
5Q
06/30/2022
22.90%
6Q
03/31/2022
24.10%
7Q
12/31/2021
3.54%
8Q
09/30/2021
15.24%
9Q
06/30/2021
1.21%
10Q
03/31/2021
1.53%
11Q
12/31/2020
17.91%
12Q
09/30/2020
19.16%
13Q
06/30/2020
19.08%
14Q
03/31/2020
19.16%
15Q
12/31/2019
23.87%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COLLEGIUM PHARMACEUTICAL INC
LOADING...